Technical Analysis for RGNX - REGENXBIO Inc.

Grade Last Price % Change Price Change
grade F 47.12 4.04% 1.83
RGNX closed up 4.04 percent on Friday, January 18, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical RGNX trend table...

Date Alert Name Type % Chg
Jan 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Jan 18 Up 3 Days in a Row Strength 0.00%
Jan 17 Inside Day Range Contraction 4.04%
Jan 15 20 DMA Support Bullish 7.36%
Jan 15 Down 3 Days in a Row Weakness 7.36%
Jan 15 Down 4 Days in a Row Weakness 7.36%
Jan 14 Down 3 Days in a Row Weakness 7.33%
Jan 11 Outside Day Range Expansion 5.23%
Jan 9 Pocket Pivot Bullish Swing Setup 0.90%
Jan 9 Narrow Range Bar Range Contraction 0.90%

Older signals for RGNX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
REGENXBIO Inc., a biotechnology company, focuses on the development, commercialization, and licensing of recombinant adeno-associated virus (AAV) gene therapy. The company's development programs include RGX-501, a product candidate for the treatment of homozygous familial hypercholesterolemia, which uses the AAV8 vector to deliver the human low-density lipoprotein receptor gene to liver cells; and RGX-111, a product candidate for the treatment of Mucopolysaccharidosis Type I, which uses the AAV9 vector to deliver the human a-l-iduronidase gene to the central nervous system. Its programs also include RGX-121, a product candidate for the treatment of Mucopolysaccharidosis Type II; RGX-314, a product candidate for the treatment of wet age-related macular degeneration; and RGX-321, a product candidate for the treatment of X-linked retinitis pigmentosa. The company was formerly known as REGENX Biosciences, LLC and changed its name to REGENXBIO Inc. in September 2014. REGENXBIO Inc. was founded in 2008 and is headquartered in Rockville, Maryland.
Is RGNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 85.1
52 Week Low 23.25
Average Volume 509,537
200-Day Moving Average 58.9315
50-Day Moving Average 52.6144
20-Day Moving Average 43.461
10-Day Moving Average 45.27
Average True Range 3.0721
ADX 26.89
+DI 18.7998
-DI 19.7984
Chandelier Exit (Long, 3 ATRs ) 40.3537
Chandelier Exit (Short, 3 ATRs ) 47.7763
Upper Bollinger Band 48.1005
Lower Bollinger Band 38.8215
Percent B (%b) 0.89
BandWidth 21.350176
MACD Line -1.5561
MACD Signal Line -2.4819
MACD Histogram 0.9258
Fundamentals Value
Market Cap 1.46 Billion
Num Shares 30.9 Million
EPS -2.69
Price-to-Earnings (P/E) Ratio -17.52
Price-to-Sales 99.62
Price-to-Book 4.15
PEG Ratio 1.02
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 50.23
Resistance 3 (R3) 50.03 48.79 49.71
Resistance 2 (R2) 48.79 48.00 48.89 49.53
Resistance 1 (R1) 47.96 47.51 48.38 48.16 49.36
Pivot Point 46.72 46.72 46.93 46.82 46.72
Support 1 (S1) 45.89 45.93 46.31 46.09 44.88
Support 2 (S2) 44.65 45.44 44.75 44.71
Support 3 (S3) 43.82 44.65 44.53
Support 4 (S4) 44.02